Literature DB >> 20960162

Identification of novel transcript variants of estrogen receptor α, β and progesterone receptor gene in human endometrium.

Anette Springwald1, Claus Lattrich, Maciek Skrzypczak, Regina Goerse, Olaf Ortmann, Oliver Treeck.   

Abstract

The human progesterone receptor (PR) and estrogen receptor genes (ESR1 and ESR2) are known to code for a multitude of transcript variants resulting from alternative splicing. Many of them are translated into nuclear receptor proteins with altered structure and function. Expression of these alternative estrogen and progesterone receptors modulates the cellular response to sexual steroid hormones. Recent studies also suggested their significance in development of hormone-dependent diseases like gynecological cancers. We report identification of 12 new transcript variations of the PR, ESR1, and ESR2 gene in human endometrium which result from differential exon-skipping. We succeeded in cloning of four new double or triple exon-deletion transcript variants of ERα, four single, double or triple exon-skipped mRNA isoforms of ERβ, and four new transcript variations of PR gene. Sequence analysis suggested that at least four of them, ERαΔ5/6, ERαΔ5/6/7, PRΔ7, and PRΔ6/7 are translated into receptor proteins which might exert ligand-independent effects on steroid hormone signalling. Comparison of pre- and post-menopausal endometrium revealed differential expression of PRΔ6/7, ERαΔ5/6/7, ERαΔ3/4/5, and ERβΔ1-0N. We also report differential expression of the exon-skipped isoforms in a panel of human cancer cell lines derived from the breast, ovary, and endometrium. Our identification of additional transcript variations further increases the complexity of steroid hormone receptor gene expression and signalling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960162     DOI: 10.1007/s12020-010-9322-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  48 in total

1.  ER beta: identification and characterization of a novel human estrogen receptor.

Authors:  S Mosselman; J Polman; R Dijkema
Journal:  FEBS Lett       Date:  1996-08-19       Impact factor: 4.124

2.  Estrogen receptor beta splice variant mRNAs are differentially altered during breast carcinogenesis.

Authors:  Indra Poola; Jessy Abraham; Aiyi Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2002-10       Impact factor: 4.292

3.  A splice variant of estrogen receptor beta missing exon 3 displays altered subnuclear localization and capacity for transcriptional activation.

Authors:  R H Price; C A Butler; P Webb; R Uht; P Kushner; R J Handa
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

4.  Structure of the human progesterone receptor gene.

Authors:  M Misrahi; P Y Venencie; P Saugier-Veber; S Sar; P Dessen; E Milgrom
Journal:  Biochim Biophys Acta       Date:  1993-11-16

5.  Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.

Authors:  M P A Davies; P A O'Neill; H Innes; D R Sibson; W Prime; C Holcombe; C S Foster
Journal:  J Mol Endocrinol       Date:  2004-12       Impact factor: 5.098

6.  The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.

Authors:  P H Giangrande; E A Kimbrel; D P Edwards; D P McDonnell
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern.

Authors:  E Enmark; M Pelto-Huikko; K Grandien; S Lagercrantz; J Lagercrantz; G Fried; M Nordenskjöld; J A Gustafsson
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

8.  A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform.

Authors:  C A Sartorius; M Y Melville; A R Hovland; L Tung; G S Takimoto; K B Horwitz
Journal:  Mol Endocrinol       Date:  1994-10

9.  Variant human breast tumor estrogen receptor with constitutive transcriptional activity.

Authors:  S A Fuqua; S D Fitzgerald; G C Chamness; A K Tandon; D P McDonnell; Z Nawaz; B W O'Malley; W L McGuire
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

10.  Genomic organization of the human oestrogen receptor gene.

Authors:  M Ponglikitmongkol; S Green; P Chambon
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

View more
  5 in total

1.  Female Reproductive Systems: Hormone Dependence and Receptor Expression.

Authors:  Kevin K W Kuan; Philippa T K Saunders
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol.

Authors:  Vicki L Davis; Retha R Newbold; John F Couse; Sheri L Rea; Katie M Gallagher; Katherine J Hamilton; Eugenia H Goulding; Wendy Jefferson; E M Eddy; Bill C Bullock; Kenneth S Korach
Journal:  Reprod Toxicol       Date:  2012-08-31       Impact factor: 3.143

3.  Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative.

Authors:  David M W Cork; Thomas W J Lennard; Alison J Tyson-Capper
Journal:  Tumour Biol       Date:  2012-09-07

4.  Emergency contraception: an updated review.

Authors:  M Guida; M L Marra; V Palatucci; R Pascale; F Visconti; F Zullo
Journal:  Transl Med UniSa       Date:  2011-10-17

5.  Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.

Authors:  Frederik Holst; Erling A Hoivik; William J Gibson; Amaro Taylor-Weiner; Steven E Schumacher; Yan W Asmann; Patrick Grossmann; Jone Trovik; Brian M Necela; E Aubrey Thompson; Matthew Meyerson; Rameen Beroukhim; Helga B Salvesen; Andrew D Cherniack
Journal:  Sci Rep       Date:  2016-05-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.